This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens.

A carcinogen is something that could cause you to have cancer.

The new recall brings the list of blood pressure medications recalled since October to 15.

All have been found to have trace amounts of N-nitrosodiethylamine (NDEA) and are manufactured by different companies.

Here’s the latest list from the FDA:

Torrent Pharmaceuticals Limited

Losartan potassium and Hydrochlorothiazide tablets, USP


Prinston Pharmaceutical Inc. dba Solco Healthcare LLC

Irbesartan and Irbesartan HCTZ Tablets


Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited

Amlodipine Valsartan Tablets USP

Valsartan HCTZ Tablets USP

Valsartan Tablets USP

Losartan potassium tablets, USP

Irbesartan Drug


Mylan Pharmaceuticals

Valsartan-containing products

Amlodipine and Valsartan Tablets

Valsartan and Hydrochlorothiazide Tablets


Teva Pharmaceuticals

Amlodipine/Valsartan Combination Tablets

Amlopidine/Valsartan/Hydrochlorothiazide Combination Tablets


Sandoz Inc.

Losartan Potassium Hydrochlorothiazide


ScieGen Pharmaceuticals, Inc

      • Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms (Under brand name Westminster)

You can check out all the latest drug recalls here.

So far all the recalls are voluntary.